65 related articles for article (PubMed ID: 8438284)
1. HLA-A2-specific antibody production in severe combined immunodeficient mice reconstituted with human peripheral blood leukocytes from HLA-presensitized donors.
Niguma T; DeVito LD; Grailer AP; Fechner JH; Sollinger HW; Burlingham WJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):239-40. PubMed ID: 8438284
[No Abstract] [Full Text] [Related]
2. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
[TBL] [Abstract][Full Text] [Related]
3. Production of human sperm-immobilizing antibodies in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood lymphocytes from infertile women.
Shibahara H; Tsuji Y; Koyama K
Am J Reprod Immunol; 1996 Jan; 35(1):57-60. PubMed ID: 8789561
[No Abstract] [Full Text] [Related]
4. Human leukocyte antigen-DR matching improved skin graft survival from transgenic pigs to accommodate SCID mice reconstituted with human peripheral blood mononuclear cells.
Tu CF; Tai HC; Chen CM; Huang TT; Lee JM; Yang TS; Chen CH; Tseng YL; Chou NK; Lee PH
Transplant Proc; 2008 Mar; 40(2):578-80. PubMed ID: 18374133
[TBL] [Abstract][Full Text] [Related]
5. Activation of HLA-A2-specific memory B cells in severe combined immunodeficient mice.
Niguma T; DeVito LD; Grailer AP; Fechner JH; Sollinger HW; Burlingham WJ
Hum Immunol; 1993 May; 37(1):7-16. PubMed ID: 8376189
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
[TBL] [Abstract][Full Text] [Related]
7. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
[TBL] [Abstract][Full Text] [Related]
8. Promiscuity of the AlloHLA-A2 restricted T cell repertoire hampers the generation of minor Histocompatibility antigen-specific cytotoxic T cells across HLA barriers.
Oosten LE; Blokland E; Kester MG; Falkenburg JH; van Halteren AG; Goulmy E
Biol Blood Marrow Transplant; 2007 Feb; 13(2):151-63. PubMed ID: 17241921
[TBL] [Abstract][Full Text] [Related]
9. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
10. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
Jackson DJ; Kumpel BM
Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288
[TBL] [Abstract][Full Text] [Related]
12. Targeting p53 for adoptive T-cell immunotherapy.
McCarty TM; Liu X; Sun JY; Peralta EA; Diamond DJ; Ellenhorn JD
Cancer Res; 1998 Jun; 58(12):2601-5. PubMed ID: 9635585
[TBL] [Abstract][Full Text] [Related]
13. SCID-hu-PBL: a model for making human antibodies?
Ifversen P; Borrebaeck CA
Semin Immunol; 1996 Aug; 8(4):243-8. PubMed ID: 8883147
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival of HLA-DR15+ pig skin in SCID mice after reconstitution with human peripheral blood mononuclear cells and under short-term immunosuppression.
Tai HC; Tu CF; Lee JM; Ho LL; Tseng YL; Chou NK; Yang TS; Weng CN; Lee PH; Chang KJ; Tang YB
Transplant Proc; 2008 Mar; 40(2):570-3. PubMed ID: 18374131
[TBL] [Abstract][Full Text] [Related]
15. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
[TBL] [Abstract][Full Text] [Related]
16. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
Reilly RT; Machiels JP; Emens LA; Ercolini AM; Okoye FI; Lei RY; Weintraub D; Jaffee EM
Cancer Res; 2001 Feb; 61(3):880-3. PubMed ID: 11221874
[TBL] [Abstract][Full Text] [Related]
17. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers.
Bharat A; Benshoff N; Fleming TP; Dietz JR; Gillanders WE; Mohanakumar T
Breast Cancer Res Treat; 2008 Aug; 110(3):453-63. PubMed ID: 17874294
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
[TBL] [Abstract][Full Text] [Related]
20. Activated B cells mediate efficient expansion of rare antigen-specific T cells.
Zentz C; Wiesner M; Man S; Frankenberger B; Wollenberg B; Hillemanns P; Zeidler R; Hammerschmidt W; Moosmann A
Hum Immunol; 2007 Feb; 68(2):75-85. PubMed ID: 17321896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
